Answer
After absorption, nabumetone is rapidly converted in the liver to its principal active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA), which strongly inhibits prostaglandin synthesis.
Sources for this answer
- Nabumetone 500 mg film-coated TabletsTillomed Laboratories Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked